Welcome, Guest  
Sign In | Register | About Us | Help  

Find:
  What is RSS?
 
Contact Us
    Submit a site
    Give us feedback
 Related Solutions
 
ROC Maestro for Open Systems
Data Migration Solution - Rapid Implementations
Data Integration Solution - Rapid Implementations
EMBASSY Trusted Drive Manager
Business Process Outsourcing for Life and Annuities
...more solutions

 Related Research
 
File Shares to SharePoint: 8 Keys to a Successful Migration
Always Be Open for Business: iSeminar
Understanding and Selecting a Database Activity Monitoring Solution
Recovering Systems up to 20 Times Faster with Solutions from Symantec and OFM Computer ...
Increase First Contact Resolution: The Key to Superior Support
...more research


Your search for: site:www.biotechnologyhealthcare.com Healthcare Administration returned 34 results
Showing 1 - 20 results | <<   <   1 2   >   >>

Mode of administration A factor in biologic drug costs
Of drugs in late stages of development, 73 percent will need to be administered by a healthcare provider, with the bulk of those being administered intravenously. Sixty percent of drugs in late stages of compliance is often poor, resulting in additional costs to get the patient back on track. In-office administration of bio- pharmaceuticals reduce...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/1/4/BH0104064.pdf
Cached View

CMS Introduces New Payment Rates for Drugs and Their Adminis ....
To avert that, CMS is working with carriers and CMS regional offices. HELP FOR PRIVATE PAYERS At the than 120 percent higher than in 2003. In addition, physicians will have more opportunities to bill for administration services (see table). These provisions offset the loss of generous “transition payments” made last year to physicians in ment is....
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/1/BH0201017.pdf
Cached View

Biotechnology Healthcare - Daily News
Biotechnology Healthcare - Daily News A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community percent). Monday, Jun 18 Canfosfamide Trials Changed to Partial Hold Status Telik announced that the U.S. Food and Drug Administration has converted the recently announced full clinical hold...
Url: http://www.biotechnologyhealthcare.com/daily/
Cached View

Biotechnology Healthcare Journal
June 2006 February April June August October December 2005 February April June August October December 2004 March May July/August September October December About Biotechnology Healthcare Journal Call for Papers Conflict-of-interest form (PDF) Writers’ Guidelines Masthead Editorial Board Subscriptions Reprints September 2004 Features Clinical How ...
Url: http://www.biotechnologyhealthcare.com/journal/journalview.cfm?volume=1&issu ...
Cached View

Biotechnology Healthcare Journal
Biotechnology Healthcare Journal A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community → CE June 2006 February April June August October December 2005 February April June August October December 2004 March May July/August September October December About Biotechnology Healthcare Jo...
Url: http://www.biotechnologyhealthcare.com/journal/journalview.cfm?volume=1&issu ...
Cached View

Biotechnology Healthcare Journal
Biotechnology Healthcare Journal A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community → CE June 2006 February April June August October December 2005 February April June August October December 2004 March May July/August September October December About Biotechnology Healthcare Jo...
Url: http://www.biotechnologyhealthcare.com/journal/journalview.cfm?volume=3&issu ...
Cached View

Biotechnology Healthcare Journal
Biotechnology Healthcare Journal A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community → CE June 2006 February April June August October December 2005 February April June August October December 2004 March May July/August September October December About Biotechnology Healthcare Jo...
Url: http://www.biotechnologyhealthcare.com/journal/journalview.cfm?volume=2&issu ...
Cached View

Biotechnology Healthcare Journal
Biotechnology Healthcare Journal A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community → CE June 2006 February April June August October December 2005 February April June August October December 2004 March May July/August September October December About Biotechnology Healthcare Jo...
Url: http://www.biotechnologyhealthcare.com/journal/journalview.cfm?volume=2&issu ...
Cached View

Biotechnology Healthcare - Daily News
Biotechnology Healthcare - Daily News A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community Over three million prescriptions have been written in the U.S. since being approved by the Food and Drug Administration (FDA) in 2005. For more information, visit www.byetta.com. About Byett...
Url: http://www.biotechnologyhealthcare.com/Daily/DailyDetail.cfm?chosen=1109
Cached View

Biotechnology Healthcare - Daily News
Biotechnology Healthcare - Daily News A GUIDE FOR DECISION MAKERS ON THE BIOTECHNOLOGY REVOLUTION MORE MEDIMEDIA SITES: → Managed Care Journal → P&T Community States for combination HIV therapy. Viread received approval as an anti-HIV medication from the U.S. Food and Drug Administration (FDA) in October 2001 and from the European Commission in Fe...
Url: http://www.biotechnologyhealthcare.com/Daily/DailyDetail.cfm?chosen=1108
Cached View

Intravenous Drugs May Be Losing Favor
According to The Zitter Group’s Fall 2005 Managed Care Injectables Index, the use of carve-out of the index, below, outlines some payer attitudes that may underpin this trend. Patient management issues, the difficulty of negotiating administration fees with physicians, ASP-based reimbursements, and the effect of Medicare Part D also may help to.....
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/3/1/BH0301064.pdf
Cached View

Biotech Cheers 4 More Years, But Familiar Struggles Still Ah ....
With Bush in sought to limit research. On the federal level, Bush’s track record on price controls and re- importation — his administration has steadfastly opposed both — was enough to leave biotech leaders feeling bullish about the near-term. But with drug prices making the elections. But the old issues of reimportation and potential price...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/1/6/BH0106012.pdf
Cached View

Approvals, FDA Actions, Clinical Trials
AUGUST 2005 · BIOTECHNOLOGY HEALTHCARE 13 DRUGTRACK CLINICAL TRIALS/ DRUG DEVELOPMENT Cetuximab (Erbitux), in combi- nation with radiation therapy, prevented the spread of head Remicade) for treat- ment of ulcerative colitis has been granted priority review by the U.S. Food and Drug Administration. The sBLA is based on two phase 3 trials in patien...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/4/BH0204013.pdf
Cached View

Specialty Drug Costs Continue To Rise; Employees Hit With Hi ....
18 BIOTECHNOLOGY HEALTHCARE · DECEMBER 2005 BIOTECH BUSINESS “We have had a 5 percent de- cline in the number of workers covered GUIDE AND TREND REPORT 2004; IMS HEALTH 2005, WALL STREET EQUITY RESEARCH 2004, CENTERS FOR MEDICARE AND MEDICAID NATIONAL HEALTHCARE EXPENDITURE PROJECTION 2003–2013 DECEMBER 2005 · BIOTECHNOLOGY HEALTHCARE 19 adminis...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/6/BH0206018.pdf
Cached View

Marking the Progress of Genetic Testing
APRIL 2005 · BIOTECHNOLOGY HEALTHCARE 15 DRUGS AND DIAGNOSTICS lesions could be excised, and the cancer risk reduced. When no preventive strategies or cures exist scheduled for annual colonos- copies, during which precancerous Marking the Progress of Genetic Testing BY BOB CARLSON 16 BIOTECHNOLOGY HEALTHCARE · APRIL 2005 DRUGS AND DIAGNOSTICS The ...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/2/BH0202015.pdf
Cached View

Biotech Pipeline Set For Future Sales Growth
S. Food and Drug Administration review for market approval. Nearly 50 percent of all new medicines approved by the FDA in 2003 brimming with drugs targeting central nervous system and cardiovascular disorders — Amanda Brower Biotech Pipeline Set For Future Sales Growth 64 BIOTECHNOLOGY HEALTHCARE · JULY/AUGUST 2004 SOURCE: RESURGENCE: GLOBAL...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/1/3/BH0103064.pdf
Cached View

Biotech developing 324 new products
150 diseases. These poten- tial new drugs are either under review for approval by the U.S. Food and Drug Administration or in human clinical trials. A closer look finds 154 investigational cancer drugs, accounting for 48 percent of FDA approval will supplement the 108 biotechnology drugs already on the market. — Amanda Brower Biotech developing 32...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/1/6/BH0106064.pdf
Cached View

Number of Monoclonal Antibodies on Market Nearly Doubles by ....
Based on an analysis of past approval rates, Tufts projects that by 2008, the U.S. Food and Drug Administration is likely to approve 11 of the current mAb products in the pipeline.* In effect the bulk of mAb sales — $7.2 billion, or 43 percent of the total mAb market. — Amanda Brower 64 BIOTECHNOLOGY HEALTHCARE · JUNE 2005 SOURCES: PROTEIN...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/3/BH0203064.pdf
Cached View

Base Hits
S. Food and Drug Administration has approved a number of pharmaco- genomic products. This gives us con- fidence in the prospect of Global Technology Centre and Health Re- search Institute of PriceWaterhouse- Coopers. February 2005. DAVID B. NASH, MD, MBA EDITORIAL 6 BIOTECHNOLOGY HEALTHCARE...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/5/BH0205006.pdf
Cached View

Approvals, FDA Actions, Clinical Trials
10 BIOTECHNOLOGY HEALTHCARE · OCTOBER 2005 DRUGTRACK mental therapy for non-small cell lung cancer (NSCLC) — seeking ap- proval for use in women supplement) (Influenza Pasteur injection virus vaccine) Aug. 18, 2005 FluMist (In- MedImmune 2005–2006 U.S. formulation Nasal 0.5 ml (supplement) fluenza virus administration vaccine, live) Aug. 31, 2005 ...
Url: http://www.biotechnologyhealthcare.com/journal/fulltext/2/5/BH0205010.pdf
Cached View

 
 
  >  About Us       >  Site Feedback       >  Submit a Site
Sites Powered by KnowledgeStorm
 
Business Solutions Accounting , Business Intelligence , Business Process Management , Computer Maintenance Management Systems (CMMS) , Content Management , Corporate Compliance Management , Customer Management , Customer Relationship Management , Distribution Management , Document Control , Education , Employee Scheduling , Enterprise Asset Management (EAM) , Enterprise Information Integration , Enterprise Performance Management , Enterprise Resource Planning , Expense Management , Field Service Management , FindTech - Technology Search , FindTech Blogs , FindTech Insights , Human Capital Management , Human Resources , Information Lifecycle Management , Inventory Management , Knowledge Management , Lean Manufacturing , Maintenance, Repair and Operating , Make-to-Order Manufacturing , Manufacturing Execution System , Marketing Management , Material Requirements Planning , Mobile Computing , Mobile Field Sales , Non-Profit , Outsourcing , Procurement , Product Data Management , Product Lifecycle Management , Project Management , Purchasing , Radio Frequency Identification , Records Management , Sales Force Automation , Small and Medium Business , Small/Mid-Sized CRM , Spend Management , Supply Chain Management , Technology Services Directory , Time and Attendance , Video Conferencing , Warehouse Management
 
 
Technical Solutions Anti Spam , Anti Virus , Application Development , Application Implementation , Backup , Call Center , Customer Service , Data Center Management , Data Integration , Data Warehousing , Database , Disaster Recovery , Document Management , E-mail Management , E-mail Marketing , Enterprise Application Integration , Groupware , IT Performance Management , IT Portfolio Management , Java , Linux , Messaging , Network Administration , Networking , Quality Assurance , Remote Access , Security , Server Optimization , Servers , Service Oriented Architecture SOA , Software Configuration Management , Software Testing , Storage , Systems Management , Unix , Visual Basic , Web Design , Web Development , Web Hosting , Web Services , Web Traffic Analysis , Windows , Wireless , Workflow
 
 
Geographically-based Solutions Australia , Canada , Germany , India , New Zealand , United Kingdom
 
 
KnowledgeStorm Partners BusinessWeek , Byte.com , CPA Technology Advisor , CRM Buyer , CRMindustry , CXO America , CallCenterOps , DownloadITSoftware - Get Business Software Trials , Dr.Dobbs Journal , E-Commerce Times , FierceCIO , FierceFinance , FierceHealthcare , FierceWireless , Government Computer News , HRE Online , HRM Report , IncTechnology.com , Industrial Distribution , InfoWorld , LinuxInsider , Manufacturing Business Technology , Modern Healthcare , Modern Physician , Purchasing.com , SearchITChannel , SearchNetworkingChannel , SearchSecurityChannel , SearchStorageChannel , SearchSystemsChannel , SecurityInfoWatch.com , Small Business Technology Advisor , Software Magazine , Supply and Demand Chain Executive , SysAdmin Magazine , Tech Decisions , TechNewsWorld , UnixReview.com
 
 
Vertical Searches Telecom
 
 
Submit a Site   |   About KnowledgeStorm   |   Contact Us   |   Help
Related Searches: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |